Azacytosine analogs and derivatives

Abstract

Compounds and compositions of azacytosine analogs and derivatives are provided. In one aspect of the invention, analogs or derivatives of decitabine and azacitidine are provided with modification at the 2-, 4-, or 6-position of the triazine ring, at the 1′-6′position of the ribose ring, or combinations thereof. Methods of using, synthesizing and manufacturing these analogs and derivatives are also provided. These compounds can be formulated into pharmaceutical compositions that can be used for treating any disease associated with aberrant DNA methylation, or a disease or condition that is sensitive to the treatment with decitabine or azacitidine, such as hematological disorders, tumors and cancers.

Description

CROSS-REFERENCE [0001] This application is a continuation-in-part application of Ser. No. 11 / 077,862, filed Mar. 11, 2005, which is incorporated herein by reference in its entirety and to which application we claim priority under 35 USC §120.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The present invention relates to compounds and compositions of cytosine analogs and derivatives, and methods for preparing, formulating and administering these compounds or compositions to a host in need thereof. [0004] 2. Description of Related Art [0005] A few nucleosides of azacytosine, such as 5-aza-2′-deoxycytidine (also called decitabine, FIG. 1A, structure 1a) and azacitidine (FIG. 1A, structure 1b), have been developed as antagonist of its related natural nucleoside, cytidine and 2′-deoxycytidine, respectively. The only structural difference between azacytosine and cytosine is the presence of a nitrogen atom at position 5 of the cytosine ring in azacytosine as compared t...

AI Technical Summary

Benefits of technology

[0019] In another variant of the embodiment, group Rx of Formula I is preferably a strong electron-donating group such as hydroxyl, thiol, primary, secondary or tertiary amino, —O-alkyl, —S-alkyl, —O-aryl and —S-aryl. Strong electron-donating group is defined as the class of chemical moieties that can decrease the electrophilicity of an adjacent site by resonance or inductive effects.

Problems solved by technology

At a cellular level, decitabine can induce cell differentiation and exert hematological toxicity.

Substituting the carbon at the 5 position of the cytosine for a nitrogen interferes with this normal process of DNA methylation.

Images